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Introduction / objectives
Changing an antimicrobial treatment regimen has
shown to influence the occurrence of antimicrobial
resistance, with regimen consisting of the dose, the
treatment interval, the duration of therapy, and the
route of administration of the drug. For concentration
dependent antimicrobials there is substantial evidence to
encourage the use of a high dose, with regular treatment
interval and short course to minimise the risk for the
selection of resistant mutants. However, in contrast with
these first three aspects of the antimicrobial treatment
regimen, little attention is currently paid to the influ-
ence of route of administration for the probability of
selection and spread of resistant strains.
Methods
By comparing data from different animal species, the
purpose is to explore the different routes of administra-
tion with regard to the stimulation of antimicrobial
resistance.
Results
A historical review on the emergence of resistance to
beta-lactamas and tetracycline in Staphylococcus aureus
and Escherichia coli in different animal species and
humans will be provided. Data on commonly used treat-
ment regimens for humans and animal will be compared
and the potential impact on selection, co-selection and
spread of resistance will be discussed escriptively. Spe-
cial attention will be given to the difference in resistance
development between topical, oral, and parenteral
administration of antimicrobial agents.
Conclusion
Attention to the route of administration might be an
underestimated approach to mitigate the risk of
selection for pathogens resistant to antimicrobials in
both human and veterinary medicine.
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